跳至主要内容
临床试验/CTRI/2024/07/071008
CTRI/2024/07/071008尚未招募3 期

Randomized controlled clinical trial to study efficacy of Vasa Ghrita Tarpana and Triphala Ghrita Tarpana in the management of Simple Myopia.

Tilak Ayurveda Mahavidyalaya1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年7月26日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Decrease in Headache, Eyestrain

研究概览

简要总结

The study will be intervened by the treatment of Vasa Ghrita Tarpana and Triphala Ghrita Tarpana to group A and group B respectively. The efficacy of the therapy will be assessed on the basis of subjective criteria for statistical analysis. scoring will be designed according to severity of symptoms. the subjective gradation of symptoms will be done as follows and intensity of each symptoms will be calculated before treatment, after treatment and after follow up. The effect of treatment result will be assessed in regards to clinical signs and symptoms on basis of grading and scoring system. The signs and symptoms will be assessed by adopting suitable scoring method.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
16.00 Year(s) 至 25.00 Year(s)(—)
性别
All

入选标准

  • Simple Myopia Spherical No.:- -0.25 to -3.00D.

排除标准

  • Other clinical types of Timira like Cataract,Glaucoma,Presbyopia,Hypermetropia will be excluded.

结局指标

主要结局

Decrease in Headache, Eyestrain

时间窗: 30 days and 60 days

, Blurring of Vision

时间窗: 30 days and 60 days

次要结局

  • Decrease in Blurring of Vision(90 days)

研究者

发起方
Tilak Ayurveda Mahavidyalaya
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Sayali Patil

Tilak Ayurveda Mahavidyalaya

研究点 (1)

Loading locations...

相似试验